Amy Morgan
Family · Reddick, FLNPI 1396254488
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.3% of the total across 158 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 22.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $793 and has fallen 52.8% since, to $374 in 2025.
Across 158 payments — averaging $19.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$682
- Lilly USA, LLC$614
- Eisai Inc.$578
- Merck$198
- Pharmacyclics LLC, An Abbvie Company$144
- Johnson & Johnson$138
- plus $679 from 19 others
What the payments were for
- Food & beverage$2,92396%
- Education$1114%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 38 | $682 |
| Lilly USA, LLC | 35 | $614 |
| Eisai Inc. | 29 | $578 |
| Merck | 10 | $198 |
| Pharmacyclics LLC, An Abbvie Company | 6 | $144 |
| Johnson & Johnson | 7 | $138 |
| Karyopharm Therapeutics Inc. | 8 | $128 |
| Genentech USA, Inc. | 4 | $67 |
| Astellas Pharma US Inc | 1 | $65 |
| GSK | 2 | $43 |
| Beigene USA, Inc. | 2 | $42 |
| Sun Pharmaceutical Industries Inc. | 1 | $42 |
| Ipsen Biopharmaceuticals, Inc | 2 | $34 |
| Boehringer Ingelheim | 1 | $32 |
| Janssen Scientific Affairs, LLC | 1 | $32 |
| Beone Medicines USA, Inc. | 1 | $28 |
| Myovant Sciences Inc. | 2 | $27 |
| AVEO Pharmaceuticals, Inc. | 1 | $21 |
| Novo Nordisk | 1 | $21 |
| Pfizer | 1 | $18 |
| Iovance Biotherapeutics, Inc. | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| Exact Sciences | 1 | $17 |
| AstraZeneca | 1 | $13 |
| Sumitomo Pharma America, Inc. | 1 | $13 |
How this compares
$3,034 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 34 | $40,332 |
| JanuviaSitagliptin Phosphate | 16 | $18,744 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $10,686 |
| Levothyroxine Sodium | 67 | $978 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $939 |
| Gabapentin | 39 | $790 |
| FenofibrateFenofibrate Nanocrystallized | 19 | $534 |
| Lisinopril | 94 | $484 |
| Metformin Hcl | 88 | $462 |
| Pravastatin Sodium | 13 | $398 |
| Rosuvastatin Calcium | 34 | $373 |
| Atorvastatin Calcium | 56 | $341 |
| Trazodone Hcl | 27 | $314 |
| Omeprazole | 26 | $297 |
| Amlodipine Besylate | 75 | $285 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $21 | $40,33234 claims |
| MerckJanuvia | $198 | $18,74416 claims |
| GSKTrelegy Ellipta | $43 | $10,68611 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $17 | $97867 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 14,618 family providers in Florida.
Other family in Reddick
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.